This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 May;4(5):361-70.

doi: 10.1038/nrc1360.

The discovery of receptor tyrosine kinases: targets for cancer therapy

Andreas Gschwind¹, Oliver M Fischer, Axel Ullrich

Affiliations

PMID: 15122207
DOI: 10.1038/nrc1360

Review

The discovery of receptor tyrosine kinases: targets for cancer therapy

Andreas Gschwind et al. Nat Rev Cancer. 2004 May.

. 2004 May;4(5):361-70.

doi: 10.1038/nrc1360.

Authors

Andreas Gschwind¹, Oliver M Fischer, Axel Ullrich

Affiliation

¹ Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.

PMID: 15122207
DOI: 10.1038/nrc1360

No abstract available

PubMed Disclaimer

Similar articles

Origins of cancer therapy.
Papac RJ. Papac RJ. Yale J Biol Med. 2001 Nov-Dec;74(6):391-8. Yale J Biol Med. 2001. PMID: 11922186 Free PMC article.
Cancer chemotherapy: an annotated history.
Morrison WB. Morrison WB. J Vet Intern Med. 2010 Nov-Dec;24(6):1249-62. doi: 10.1111/j.1939-1676.2010.0590.x. Epub 2010 Sep 14. J Vet Intern Med. 2010. PMID: 20840315
We fought cancer...and cancer won.
Begley S. Begley S. Newsweek. 2008 Sep 15;152(11):42-4, 46, 57-8 passim. Newsweek. 2008. PMID: 18800570 No abstract available.
Chronic myeloid leukemia: a historical perspective.
Goldman JM. Goldman JM. Semin Hematol. 2010 Oct;47(4):302-11. doi: 10.1053/j.seminhematol.2010.07.001. Semin Hematol. 2010. PMID: 20875546 Review.
The historical development of cancer chemotherapy.
Burchenal JH. Burchenal JH. Semin Oncol. 1977 Jun;4(2):135-46. Semin Oncol. 1977. PMID: 327552 Review. No abstract available.

See all similar articles

Cited by

An in vivo C. elegans model system for screening EGFR-inhibiting anti-cancer drugs.
Bae YK, Sung JY, Kim YN, Kim S, Hong KM, Kim HT, Choi MS, Kwon JY, Shim J. Bae YK, et al. PLoS One. 2012;7(9):e42441. doi: 10.1371/journal.pone.0042441. Epub 2012 Sep 5. PLoS One. 2012. PMID: 22957020 Free PMC article.
Inferring active and prognostic ligand-receptor pairs with interactions in survival regression models.
Ruggeri C, Eng KH. Ruggeri C, et al. Cancer Inform. 2015 Jan 26;13(Suppl 7):67-75. doi: 10.4137/CIN.S16351. eCollection 2014. Cancer Inform. 2015. PMID: 25657571 Free PMC article.
Whole Genome Duplications Shaped the Receptor Tyrosine Kinase Repertoire of Jawed Vertebrates.
Brunet FG, Volff JN, Schartl M. Brunet FG, et al. Genome Biol Evol. 2016 Jun 3;8(5):1600-13. doi: 10.1093/gbe/evw103. Genome Biol Evol. 2016. PMID: 27260203 Free PMC article.
Rational Design, Synthesis and Biological Evaluation of Novel Pyrazoline-Based Antiproliferative Agents in MCF-7 Cancer Cells.
Fakhry MM, Mahmoud K, Nafie MS, Noor AO, Hareeri RH, Salama I, Kishk SM. Fakhry MM, et al. Pharmaceuticals (Basel). 2022 Oct 10;15(10):1245. doi: 10.3390/ph15101245. Pharmaceuticals (Basel). 2022. PMID: 36297358 Free PMC article.
Design, Synthesis, Biological Evaluation, and Molecular Dynamics Studies of Novel Lapatinib Derivatives.
Elkamhawy A, Son S, Lee HY, El-Maghrabey MH, Hamd MAE, Alshammari SO, Abdelhameed AA, Alshammari QA, Abdeen A, Ibrahim SF, Mahdi WA, Alshehri S, Alnajjar R, Choi WJ, Al-Karmalawy AA, Lee K. Elkamhawy A, et al. Pharmaceuticals (Basel). 2022 Dec 28;16(1):43. doi: 10.3390/ph16010043. Pharmaceuticals (Basel). 2022. PMID: 36678540 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database